Financial Lp Hrt Acquires 7,340,178 Shares of Aditxt (NASDAQ:ADTX) Stock

Aditxt, Inc. (NASDAQ:ADTX) major shareholder Financial Lp Hrt bought 7,340,178 shares of the company’s stock in a transaction on Thursday, June 18th. The stock was purchased at an average price of $0.01 per share, with a total value of $73,401.78. Following the completion of the transaction, the insider directly owned 2,406,438 shares of the company’s stock, valued at approximately $24,064.38. The trade was a -148.78% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Monday, June 22nd, Financial Lp Hrt sold 5,120,480 shares of Aditxt stock. The stock was sold at an average price of $0.02, for a total value of $102,409.60.
• On Tuesday, June 16th, Financial Lp Hrt sold 3,132,480 shares of Aditxt stock. The shares were sold at an average price of $0.01, for a total value of $31,324.80.
• On Friday, June 12th, Financial Lp Hrt acquired 4,252,767 shares of Aditxt stock. The stock was acquired at an average price of $0.02 per share, with a total value of $85,055.34.
• On Friday, June 5th, Financial Lp Hrt sold 735,462 shares of Aditxt stock. The stock was sold at an average price of $0.06, for a total transaction of $44,127.72.
• On Thursday, June 4th, Financial Lp Hrt bought 843,622 shares of Aditxt stock. The shares were acquired at an average cost of $0.08 per share, for a total transaction of $67,489.76.
• On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The shares were sold at an average price of $7.56, for a total transaction of $8,232.84.
• On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The shares were sold at an average price of $7.83, for a total transaction of $1,104.03.
• On Tuesday, April 21st, Financial Lp Hrt purchased 2,700 shares of Aditxt stock. The shares were acquired at an average price of $8.91 per share, for a total transaction of $24,057.00.
• On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The stock was sold at an average price of $8.10, for a total transaction of $3,588.30.

Aditxt Price Performance

Shares of Aditxt stock traded down $0.03 during trading on Wednesday, hitting $0.01. The company’s stock had a trading volume of 4,650,711,153 shares, compared to its average volume of 124,214,039. The stock has a market cap of $7,929.40, a price-to-earnings ratio of -0.00 and a beta of 0.84. Aditxt, Inc. has a 52 week low of $0.00 and a 52 week high of $53,451.08. The stock has a 50-day moving average price of $3.16 and a two-hundred day moving average price of $113.78.

Aditxt (NASDAQ:ADTX) last announced its earnings results on Tuesday, March 31st. The company reported $315,563.31 EPS for the quarter. Aditxt had a negative return on equity of 374.60% and a negative net margin of 360,152.50%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ADTX. Wall Street Zen upgraded Aditxt to a “sell” rating in a report on Saturday, May 23rd. Weiss Ratings restated a “sell (e+)” rating on shares of Aditxt in a research report on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.